37 completed, 18 recruiting, 12 active not recruiting, 8 terminated. 84 Phase 1, 32 Phase 2.
Follow Nerve Sheath Neoplasms: new trials by email Literature Review of Nerve Sheath Neoplasms trials Research Report on Nerve Sheath Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor BMS-986504 - Malignant Peripheral Nerve Sheath Tumors, MPNST | Phase 1 / Phase 2 | Recruiting | Ankit Mangla, MD | 17 | 2026-08-01 | 2026-08-11 |
| Luvometinib in Combination With Serplulimab for NF2-Related Tumors Luvometinib, Serplulimab - NF2-related Schwannomatosis, NF2 | Phase 1 / Phase 2 | Not yet recruiting | Beijing Tiantan Hospital | 30 | 2026-07-31 | 2026-07-16 |
| Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II Trineumin - Neurofibromatosis Type II, NF2 | Phase 1 / Phase 2 | Not yet recruiting | PRG Science & Technology Co., Ltd. | 25 | 2026-07-01 | 2026-01-23 |
| Imaging Study of [89Zr]DFO-YS5 for Cancer Detection [89Zr]DFO-YS5, Positron Emission Tomography (PET)-Computerized tomography (CT) - Bladder Cancer, Nerve Sheath Tumor | Phase 1 | Recruiting | Robert Flavell, MD, PhD | 40 | 2026-06-15 | 2026-10-01 |
| Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas Cabozantinib Oral Tablet, Selumetinib Oral Capsule - Neurofibromatosis 1, Plexiform Neurofibroma | Phase 1 | Recruiting | Girish Dhall, MD | 30 | 2026-06-09 | 2026-10-02 |
| Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST APG-115, Selumetinib - Malignant Peripheral Nerve Sheath Tumor (MPNST), Neurofibromatosis 1 (NF1) | Phase 1 / Phase 2 | Recruiting | AeRang Kim | 45 | 2026-06-01 | 2026-07-27 |
| Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors Miltenyi CliniMACS Prodigy ® system, Zoledronic acid - Neuroblastoma, Rhabdomyosarcoma | Phase 1 / Phase 2 | Recruiting | University of Florida | 27 | 2026-02-11 | 2026-06-30 |
| Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1 Imlygic - NF1, Neurofibromatosis | Phase 1 | Recruiting | Johns Hopkins University | 10 | 2026-02-01 | 2026-05-08 |
| A Study of DEG6498 in Participants With Solid Tumors DEG6498 - Malignant Neoplasms | Phase 1 | Recruiting | Degron Therapeutics Co. | 100 | 2025-11-13 | 2026-06-30 |
| Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1 Luvometinib Tablets - Neurofibromatosis 1, Plexiform Neurofibroma | Phase 1 / Phase 2 | Not yet recruiting | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 65 | 2025-06-12 | 2025-06-17 |
| PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas PAS-004 Tablets, PAS-004 Capsule - NF1 Mutation, Neurofibroma Plexiform | Phase 1 | Recruiting | Pasithea Therapeutics Corp. | 56 | 2025-05-30 | 2026-10-28 |
| Using CICS-1 and SPM-011 and [18F]FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA BNCT, [18F]FBPA - Thoracic Solid Malignant Tumor | Phase 1 / Phase 2 | Enrolling by invitation | Stella Pharma Corporation | 30 | 2025-04-10 | 2025-11-19 |
| Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs) Kybella - Neurofibromas, Cutaneous, Neurofibromatosis 1 | Phase 1 | Enrolling by invitation | Massachusetts General Hospital | 15 | 2025-04-08 | 2026-04-22 |
| Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma AAVAnc80-antiVEGF via Akouos Delivery Device - Vestibular Schwannoma | Phase 1 / Phase 2 | Recruiting | Eli Lilly and Company | 27 | 2025-01-17 | 2026-11-04 |
| A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia Trametinib, Azacitidine, Fludarabine - Leukemia, Juvenile Myelomonocytic, JMML | Phase 1 / Phase 2 | Recruiting | Therapeutic Advances in Childhood Leukemia Consortium | 58 | 2024-10-11 | 2026-09-04 |
| NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) Surgical resection, Proton beam radiation therapy, Pazopanib - Adipocytic Neoplasm, Liposarcoma | Phase 1 / Phase 2 | Recruiting | St. Jude Children's Research Hospital | 139 | 2024-03-27 | 2026-08-03 |
| Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas Deoxycholic Acid, Polidocanol, 1064nm Nd:YAG laser - Neurofibromatosis 1 | Phase 1 | Completed | Massachusetts General Hospital | 13 | 2024-03-01 | 2025-11-21 |
| A Study of Avutometinib for People With Solid Tumor Cancers Avutometinib - Refractory Cancer, CNS Tumors | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 3 | 2023-10-20 | 2026-11-04 |
| SPEARHEAD-3 Pediatric Study Afamitresgene autoleucel - Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST) | Phase 1 / Phase 2 | Recruiting | USWM CT, LLC | 20 | 2023-09-01 | 2026-08-11 |
| Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors TNG462, Pembrolizumab - Locally Advanced Solid Tumor | Phase 1 / Phase 2 | Recruiting | Tango Therapeutics, Inc. | 225 | 2023-05-26 | 2026-09-08 |
Showing 20 of 84. Sign in to see all of them.
Neurofibrosarcoma (35) · Neurofibromatosis 1 (30) · Sarcoma (25) · Sarcoma, Synovial (16) · Rhabdomyosarcoma (13) · Leiomyosarcoma (12) · Neurofibroma, Plexiform (12) · Histiocytoma, Malignant Fibrous (11) · Liposarcoma (10) · Osteosarcoma (10) · Neuroblastoma (9) · Neurofibromatoses (9) · Sarcoma, Ewing (9) · Fibrosarcoma (8) · Hemangiosarcoma (7)
Neoplasms by Histologic Type (84) · Neoplasms, Nerve Tissue (84) · Nervous System Diseases (83) · Neoplasms (78) · Neuromuscular Diseases (72) · Peripheral Nervous System Diseases (72) · Neurofibroma (71) · Nervous System Neoplasms (62) · Peripheral Nervous System Neoplasms (62) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (49) · Genetic Diseases, Inborn (47) · Neoplastic Syndromes, Hereditary (47) · Heredodegenerative Disorders, Nervous System (41) · Neurocutaneous Syndromes (41)
AZD 6244 (9) · Deoxycholic Acid (4) · Sirolimus (4) · Doxorubicin (3) · Magnetic Resonance Spectroscopy (3) · pazopanib (3) · pembrolizumab (3) · selinexor (3) · 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (2) · Bevacizumab (2) · Cetuximab (2) · Ifosfamide (2) · Imatinib Mesylate (2) · Lasers, Solid-State (2) · Nivolumab (2)
National Cancer Institute (NCI) (14) · AstraZeneca (5) · Massachusetts General Hospital (5) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (3) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (2) · European Organisation for Research and Treatment of Cancer - EORTC (2) · Memorial Sloan Kettering Cancer Center (2) · Seattle Children's Hospital (2) · Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. (2) · St. Jude Children's Research Hospital (2) · Tango Therapeutics, Inc. (2) · AeRang Kim (1) · Ankit Mangla, MD (1) · Ascentage Pharma Group Inc. (1) · Beijing Tiantan Hospital (1)
United States (69) · China (7) · France (4) · Spain (4) · Australia (3) · Canada (3) · Japan (3) · Russia (3) · United Kingdom (3) · Denmark (2) · Germany (2) · Netherlands (2) · Austria (1) · Belgium (1) · Italy (1)
Brigitte C Widemann, M.D. (4) · Richard R Anderson, MD (3) · AeRang Kim, MD, PhD (2) · Jason R Fangusaro (2) · Aaron H. Wolfson, MD (1) · Aaron Tward, MD (1) · Albiruni Razak, M.D. (1) · Ankit Mangla, MD (1) · Antonio Omuro (1) · Brigitte C. Widemann, MD (1) · Brigitte Widemann, MD (1) · Carlos Romo, MD (1) · Carrie E Bearden, PhD (1)
PMID 11705489, PMID 12528778, PMID 12957454, PMID 15010069, PMID 15592836, PMID 19088049, PMID 21764821, PMID 22934754, PMID 23382028, PMID 25858498, PMID 26933802, PMID 28029918, PMID 30410720, PMID 31151904, PMID 31401903, PMID 32089640, PMID 32187457, PMID 33470897, PMID 33641042, PMID 34321280, PMID 34331515, PMID 35170228, PMID 35410754, PMID 35467749, PMID 36375115, PMID 36884302, PMID 37115514, PMID 37311055, PMID 37400844, PMID 38721358, PMID 38869947, PMID 39255444, PMID 39756156, PMID 40709016, PMID 41139346, PMID 41389341, PMID 41592259, PMID 42394972, PMID 42540436
P30CA008748 (2), U01CA069856 (2), UM1CA081457 (2), K08CA245181 (1), N01CM00071 (1), N01CM62206 (1), P30CA014599 (1), P50CA103175 (1), U01CA081457 (1), U10CA180821 (1)